Tigan en es it fr

Tigan Brand names, Tigan Analogs

Tigan Brand Names Mixture

  • Alphasel tablets (calcium phosphate [dibasic] + cobalt sulfate + D-alpha tocopheryl acetate + selenium sulfide)
  • Previte (neomycin sulfate + selenium sulfide + streptomycin sulfate + vitamin A + vitamin D + vitamin E + vitamin K1)

Tigan Chemical_Formula


Tigan RX_link

No information avaliable

Tigan fda sheet

Tigan msds (material safety sheet)

Tigan MSDS

Tigan Synthesis Reference

No information avaliable

Tigan Molecular Weight

280.285 g/mol

Tigan Melting Point

No information avaliable

Tigan H2O Solubility

No information avaliable

Tigan State


Tigan LogP


Tigan Dosage Forms

Intravenous (loading dose of 12 to 24 micrograms/kg over 10 minutes followed by a continuous infusion of 0.05 to 0.2 micrograms/kg per minute, adjusted according to response)

Tigan Indication

For short term treatment of acutely decompensated severe chronic heart failure (CHF).

Tigan Pharmacology

Levosimendan is a new Ca2+-sensitizing inotropic agent. Ca2+ sensitizers represent a new class of inotropic agents, which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias, cell injury and death due to Ca2+ overload in myocardial cells; they do not increase the activation energy; and they have the potential to reverse contractile dysfunction under pathophysiologic conditions, such as acidosis or myocardial stunning. Levosimendan has not been approved for use in the U.S. or Canada.

Tigan Absorption

The bioavailability of oral levosimendan is 85 ± 6% in healthy volunteers and 84 ± 4% in patients.

Tigan side effects and Toxicity

No information avaliable

Tigan Patient Information

No information avaliable

Tigan Organisms Affected

Humans and other mammals